The new COVID-19 vaccine - Comirnaty Omicron XBB.1.5 30 mcg (12+years) - will be available to New Zealanders from 7 March 2024.

IMAC and Te Whatu Ora hosted a webinar on the new vaccine this week - a recording of the webinar is available to watch here

This informative webinar covers a range of issues in relation to the new vaccine, including:

•    effectiveness and safety

•   precautions, contraindications and concomitant administration

•   use in pregnancy and breastfeeding

•   schedule and dosing information

•   post-vaccination advice

•   eligibility – primary course and additional doses

•   current COVID-19 epidemiology

•   onboarding processes for those wishing to administer the vaccines

•   practical issues and new resources

The panellists include IMAC’s programme manager Jane Morphet and medical advisor Joan Ingram, and Alison Bond - senior advisor quality national immunisation with the Prevention Directorate, National Public Health Service.

‍